Avanos Medical jumps on $25-per-share take-private agreement

Avanos Medical (AVNS) is up 69.0% today. Here is some analysis on what might have caused this price movement.

Analysis: The move appears primarily driven by Avanos announcing a definitive all-cash agreement to be acquired, which set a clear reference price for the shares. With the deal price at $25.00 per share, the stock quickly re-priced toward that level, reflecting merger-arbitrage dynamics and the large premium versus the prior close.

Details:

Avanos entered into an Agreement and Plan of Merger under which shareholders are expected to receive $25.00 in cash for each share at closing, subject to customary conditions.

The transaction values Avanos at an enterprise value of approximately $1.272 billion, and the company cited a premium of about 72.1% to the April 13, 2026 close.

The board approved the merger agreement and plans to seek stockholder approval; the deal is also subject to regulatory and other closing conditions.

The merger agreement includes a termination fee of $37.5 million payable by Avanos in specified circumstances, and the deal is not subject to a financing condition.

Sources:

PR Newswire, StockTitan (SEC filing)

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$AVNS Insider Trading Activity

$AVNS insiders have traded $AVNS stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $AVNS stock by insiders over the last 6 months:

KERR HOLBROOK (SVP, Chief Commercial Officer) has made 0 purchases and 4 sales selling 15,000 shares for an estimated $165,014.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

EARLY ACCESS

Receive AVNS Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$AVNS Hedge Fund Activity

We have seen 106 institutional investors add shares of $AVNS stock to their portfolio, and 127 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO added 14,895,480 shares (+1596514.5%) to their portfolio in Q4 2025, for an estimated $167,276,240
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 2,966,610 shares (-62.9%) from their portfolio in Q4 2025, for an estimated $33,315,030
ARMISTICE CAPITAL, LLC added 700,000 shares (+28.0%) to their portfolio in Q4 2025, for an estimated $7,861,000
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 658,119 shares (-76.4%) from their portfolio in Q4 2025, for an estimated $7,390,676
ACADIAN ASSET MANAGEMENT LLC added 525,818 shares (+123.1%) to their portfolio in Q4 2025, for an estimated $5,904,936
PACER ADVISORS, INC. removed 328,805 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $3,692,480
JPMORGAN CHASE & CO removed 304,171 shares (-52.6%) from their portfolio in Q4 2025, for an estimated $3,415,840

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$AVNS Government Contracts

We have seen $1,141,482 of award payments to $AVNS over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

EXPRESS REPORT: NX ORDERS PLACED DURING OCT 2024 - MAY 2025: $432,600
EXPRESS REPORT: NX ORDERS PLACED DURING OCT 2023 THRU SEP 2024: $333,926
EXPRESS REPORT: NX ORDERS PLACED DURING SEPTEMBER 2025: $176,954
EXPRESS REPORT: NX ORDERS PLACED DURING JULY 2025: $36,050
EXPRESS REPORT: NX ORDERS PLACED DURING AUGUST 2025: $36,050

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.